^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Kaposi Sarcoma
    Drug:pegylated liposomal doxorubicin (Topoisomerase II inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    FDA
    Excerpt:
    DOXIL is an anthracycline topoisomerase inhibitor indicated for:…AIDS-related Kaposi’s Sarcoma: After failure of prior systemic chemotherapy or intolerance to such therapy
    Evidence Level:
    Sensitive: A1 - Approval
    New
    Source:
    European Medicines Agency
    Excerpt:
    Caelyx pegylated liposomal is indicated:...for treatment of AIDS-related Kaposi’s sarcoma (KS) in patients with low CD4 counts (<200 CD4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease.
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Kaposi Sarcoma: Preferred Regimen…Liposomal Doxorubicin